Women in u.s. can now collect their own sample for cervical cancer screening

Franklin lakes, n.j. , may 15, 2024 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced u.s. food and drug administration (fda) approval for the use of self-collected vaginal specimens for human papillomavirus (hpv) testing when cervical specimens cannot otherwise be obtained.
BDX Ratings Summary
BDX Quant Ranking